RWS Holdings plc provided group earnings guidance for the year ended September 30, 2017. For the period, the Board expects Group revenues to be not less than £163 million compared to £122 million in 2016, an increase of at least 33.6%. This excellent performance has been driven by significant growth in the core translation activities, an additional month's contribution from Corporate Translations Inc., their initial US life sciences acquisition in November 2015, and a strong contribution from LUZ, their second life sciences acquisition in mid-February 2017. Adjusted profit before tax is also expected to have performed strongly and ahead of market expectations, reflecting improved gross margins, the two acquisitions and currency benefits.